Resistencia antimicrobiana en la infección urinaria por Escherichia coli adquirida en la comunidad: ¿cuál antibiótico voy a usar? / Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections: what antimicrobial to use?
Guajardo-Lara, Claudia Elena; González-Martínez, Pedro Mario; Ayala-Gaytán, Juan Jacobo.
Salud pública Méx
; 51(2): 155-159, mar.-abr. 2009. tab
Article
in Spanish
| LILACS | ID: lil-511428
OBJECTIVE:
Determine antibiotic resistance of community-acquired uropathogen Escherichia coli and infer therapeutic options. MATERIAL ANDMETHODS:
E. coli strains isolated from urine during a one-year period were studied. Identification and susceptibility tests were performed.RESULTS:
A total of 652 isolates were included from patients in two institutions, a healthcare clinic 303 (46.5 percent) and a hospital 349 ( 53.5 percent). The antimicrobials with higher resistance rates were ampicillin 67.2 percent, trimethoprim-sulfametoxazole 59.2 percent, cefazolin 35.6 percent and ciprofloxacin 24.7 percent.CONCLUSIONS:
Resistance to trimethoprim-sulfamethoxazole and ciprofloxacin used for empiric treatment in community urinary infections is high, and there are few available treatment options.
Responsible library:
BR1.1
Fulltext
Related documents